The TORC1 and PKA protein kinases are central elements of signaling networks that regulate eukaryotic cell proliferation in response to growth factors and/or nutrients. In yeast, attenuation of signaling by these kinases following nitrogen and/or carbon limitation activates the protein kinase Rim15, which orchestrates the initiation of a reversible cellular quiescence program to ensure normal chronological life span. The molecular elements linking Rim15 to distal readouts including the expression of Msn2/4-and Gis1-dependent genes involve the endosulfines Igo1/2. Here, we show that Rim15, analogous to the greatwall kinase in Xenopus, phosphorylates endosulfines to directly inhibit the Cdc55-protein phosphatase 2A (PP2A Cdc55 ). Inhibition of PP2A Cdc55 preserves Gis1 in a phosphorylated state and consequently promotes its recruitment to and activation of transcription from promoters of specific nutrientregulated genes. These results close a gap in our perception of and delineate a role for PP2A Cdc55 in TORC1-/PKA-mediated regulation of quiescence and chronological life span.
INTRODUCTION
Initiation of the quiescence program in eukaryotic cells is a highly coordinated process, which requires proper regulation of growth factor-, hormone-, and nutrient-responsive signal transduction pathways. In yeast, quiescence is primarily induced by limitation for essential nutrients following which cells cease growing, arrest cell division in the G 1 phase of the cell cycle, and acquire a distinct array of physiological, biochemical, and morphological traits. These traits collectively ensure normal chronological life span (CLS) of cells during long periods of starvation and enable them to transit back to the proliferating state upon refeeding.
The decision of yeast cells whether to initiate, or not, the quiescence program relies substantially on the information transmitted by two nutrient signaling pathways. These are the Target Of Rapamycin Complex 1 (TORC1) pathway, which is regulated by the abundance and quality of the available carbon and/or nitrogen source, and the glucose-responsive protein kinase A (PKA) pathway (De Virgilio, 2012; Gray et al., 2004 ). Attenuation of signaling by these pathways following limitation of the corresponding nutrients activates the protein kinase Rim15, which induces numerous important aspects of the quiescence program (e.g., the expression of specific nutrient-regulated genes and the accumulation of trehalose and glycogen) and critically tailors CLS (Fabrizio et al., 2001; Pedruzzi et al., 2003; Wei et al., 2008) . The molecular elements linking Rim15 to distal readouts, however, are only partially characterized. Accordingly, Rim15-dependent phosphorylation of the endosulfines Igo1/2 is essential for mRNAs, which are transcriptionally controlled by the stress response (STRE) and postdiauxic shift (PDS) transcription factors Msn2/4 and Gis1, respectively, to be sheltered from degradation via the 5 0 -3 0 mRNA decay pathway (Cameroni et al., 2004; Luo et al., 2011; Pedruzzi et al., 2000; Talarek et al., 2010) . How Rim15 coordinates transcription and posttranscriptional stability of these mRNAs, however, is still mysterious.
Here, we identify the Cdc55-protein phosphatase 2A (PP2A
Cdc55
) as an essential element that links Rim15-Igo1/2-mediated nutrient signaling to downstream effectors, which are key for proper entry into quiescence and CLS. Accordingly, when phosphorylated by Rim15 (on Ser 64 ), Igo1 directly binds to and prevents PP2A Cdc55 from dephosphorylating various target proteins including Gis1. In the latter case, conservation of a specific residue (i.e. Ser
425
) in a phosphorylated state promotes recruitment of Gis1 to promoter regions of nutrientregulated genes. All together, our data suggest a simple model in which Rim15, by activating the PP2A Cdc55 inhibitor Igo1, regulates the phosphorylation status and activity of both mRNA decay and transcription factors (such as Gis1) to coordinate entry into quiescence. Interestingly, recent studies in Xenopus have shown that the Rim15 orthologous greatwall kinase (Gwl) phosphorylates endosulfines (Ensa and Arpp19) to inhibit the protein phosphatase PP2A-B55d and consequently promote mitotic progression (Gharbi-Ayachi et al., 2010; Mochida et al., 2010) . Based on the remarkable conservation of PP2A Cdc55 regulation, which may also extend into downstream effectors, we speculate that Rim15 and Gwl may both be implicated in additional aspects of cell cycle and quiescence/CLS control, respectively.
RESULTS AND DISCUSSION
Loss of PP2A Cdc55 Enables rim15D and igo1D igo2D
Cells to Properly Enter Quiescence
To further elucidate the molecular function of Rim15 and its targets Igo1/2, we performed a genome-wide screen for mutations that are able to suppress the defect of rim15D cells in HSP26 expression during entry into quiescence (i.e. following growth for 5 days on SD plates) as described earlier (Luo et al., 2011) . The best hit in this screen turned out to be pph21D, which was not only able to suppress the defect in HSP26p-yEmRFP expression in rim15D, but also the one in igo1D igo2D doublemutant cells ( Figure 1A) . Notably, Pph21 and its partially redundant paralog Pph22 function as catalytic protein phosphatase subunits and associate with the scaffold protein Tpd3 and the regulatory subunits Cdc55 or Rts1 to form the heterotrimeric protein complexes PP2A Cdc55 or PP2A
Rts1
, respectively (Jiang, 2006) . Since rts1D did not appear among the positive hits, and since cdc55D was not scored in our suppressor screen because it was missing in the knockout collection, we deemed it likely that PP2A Cdc55 , rather than PP2A Rts1 , may play a negative role in HSP26p-yEmRFP expression in rim15D and igo1D igo2D strains. In line with this assumption, we observed that loss of Cdc55 enabled rim15D as well as igo1D igo2D cells to express HSP26p-yEmRFP ( Figure 1A ). Moreover, we also found that loss of Pph21 or of Cdc55 partially or fully suppressed, respectively, the defects in glycogen accumulation and proper setup of CLS in nutrient-limited rim15D and igo1D igo2D cells ( Figures  1B and 1C) . To corroborate our genetic data, we also quantitatively assessed the expression of RTN2, which is strongly induced in a Rim15-and Igo1/2-dependent manner following rapamycinmediated TORC1 inactivation (Talarek et al., 2010) . The data were clear: unlike loss of Rts1 or of Pph22, loss of Pph21 or of Cdc55 partially or fully suppressed, respectively, the RTN2 expression defect in rapamycin-treated rim15D and igo1D igo2D cells ( Figure 1D ; analysis of SOL4 expression yielded similar results, Figure S1B ). Notably, the combined loss of Pph21 and Pph22 rendered cells very sick, but, like loss of Cdc55, also fully suppressed the RTN2 expression defect in rapamycin-treated rim15D and igo1D igo2D cells (S.B., unpublished data). Thus, although Pph22 seemingly plays no role on its own in controlling RTN2 expression ( Figure 1D ), it appears to provide residual PP2A Cdc55 activity in the absence of Pph21. Based on both our genetic data and the recent discovery that endosulfines directly inhibit PP2A-B55d in higher eukaryotes (Gharbi-Ayachi et al., 2010; Mochida et al., 2010) , we subsequently performed two-hybrid and coimmunopreciptation (coIP) analyses to verify our assumption that Igo1 may directly interact with PP2A
Cdc55
. The two-hybrid experiments revealed that Igo1 specifically interacts with Cdc55, but not with Pph21 ( Figure 2A within Igo1 is required for it to interact with Cdc55. Our coIP analyses performed on rapamycin-treated cells largely confirmed these results. Accordingly, Igo1-myc 8 physically interacted with HA 3 -tagged Cdc55 and Pph21 ( Figure 2B , lanes 1 and 7), but not with HA 3 -tagged Rpc53, which served as negative control ( Figure 2B , lane 5 Phos-tag phosphate affinity gel electrophoresis; Figure 2B , lanes 2 and 3). Finally, Igo1-myc 8 physically interacted with HA 3 -tagged Cdc55 even in the absence of Pph21, while the interaction between Igo1-myc 8 and HA 3 -tagged Pph21 required the presence of Cdc55 ( Figure S2 ). Igo1 therefore interacts with Pph21 indirectly via Cdc55.
To test whether Igo1 affects the phosphatase activity of PP2A
, we affinity-purified the heterotrimeric PP2A Cdc55 complex from yeast (via HA 3 -tagged Cdc55) and assayed its activity using a synthetic phosphopeptide (Ser/Thr Phosphatase Substrate I) as substrate. Recombinant Igo1 thiophosphorylated in vitro by Rim15, but not Igo1 S64A or unphosphorylated Igo1, strongly inhibited the phosphatase activity of PP2A Cdc55 in a concentration-dependent manner ( Figure 2C ). Thus, analogous to the situation in higher eukaryotes, the yeast endosulfine Igo1 is converted into an inhibitor of PP2A Cdc55 by phosphorylation of its Ser 64 via the greatwall-orthologous Rim15 protein kinase.
Label-free Quantitative Proteomics Screens
Our results so far indicated that inhibition of PP2A Cdc55 by the Rim15-Igo1/2 signaling branch is key for cells to gain access to quiescence. To begin to decode the molecular events that critically affect the quiescence program, we tried to identify PP2A Cdc55 target proteins by using a label-free quantitative phosphoproteomic approach (Bodenmiller and Aebersold, 2010) . To this end, we compared the protein phosphorylation patterns of wild-type, rim15D, igo1D igo2D, and pph21D strains prior to and following a 1 hr rapamycin treatment. In total, the eight phosphorylation patterns contained 2,044 distinct phosphopeptides mapping to 830 different proteins (Table S1 ). In wild-type cells, we found 500 phosphopeptides to be significantly (i.e., >2-fold) upregulated following rapamycin treatment. Among these, the upregulation of 162 and 98 phosphopeptides was diminished more than 2-fold in rim15D and igo1D igo2D cells, respectively. To identify the most likely PP2A Cdc55 targets, we then selected, among the 64 phosphopeptides that showed diminished upregulation in both rapamycin-treated rim15D and igo1D igo2D mutant cells, the ones that were at least 1.9-fold upregulated in pph21D cells under the same conditions. Intriguingly, among the remaining 13 phosphopeptides (Table 1) , two mapped to proteins, i.e., Vts1 and Gis1, which have previously been implicated in regulating gene expression of nutrientcontrolled genes. Vts1 is a member of the Smaug family of proteins, which directly binds target mRNAs and regulates their stability by interfering with the 5 0 -3 0 mRNA decay pathway (Rendl et al., 2008) , and Gis1 is a transcription factor, which plays a key role in proper setup of quiescence and CLS downstream of Rim15 (Pedruzzi et al., 2000) . Here, we focus our analyses on Gis1, which-together with Msn2/4 that substitute to some extent Gis1 function in gis1D cells (S.B., unpublished data)-is required for rapamycin-induced RTN2 and SOL4 expression in wild-type, rim15D cdc55D, or rim15D pph21D cells ( Figures 1D  and S1B ).
Gis1 Is a PP2A
Cdc55 Target
To validate the results of our phosphoproteome studies, we examined the migration pattern of Gis1-HA 3 by phosphate affinity gel electrophoresis in different yeast strains. When analyzed in extracts of exponentially growing wild-type, rim15D and igo1D igo2D cells, Gis1-HA 3 migrated in at least three distinct bands. Following rapamycin treatment, these bands collapsed into one slow-migrating form in wild-type, but not in rim15D and igo1D igo2D cells ( Figure 3A) . The latter defect in rim15D and igo1D igo2D cells could be cured by loss of Pph21 or Cdc55. Interestingly, in exponentially growing cdc55D cells, Gis1-HA 3 was detectable only in its slow-migrating form independently of the presence or absence of Rim15 or Igo1/2 ( Figure 3A ). This was not the case in exponentially growing pph21D cells, which likely exhibit residual PP2A Cdc55 activity due to the presence of Pph22. Thus, in exponentially growing cells, PP2A Cdc55 specifically targets presumably two (or more) phosphorylated residues in Gis1, which account for the protein bands observed in wild-type samples. Together, these results indicate that in rapamycin-treated cells, Rim15-activated Igo1/2 specifically antagonize PP2A
Cdc55
-mediated dephosphorylation of Gis1. In line with this model we further found that PP2A
Cdc55 was able to dephosphorylate in vitro a synthetic phosphopeptide corresponding in sequence to the flanking regions of the predicted Pph21 target residue pSer 425 within Gis1 ( Table 1 ), and that Igo1-pSer 64 strongly inhibited this activity in a concentration-dependent manner ( Figure 2C ). Moreover, in coIP experiments using extracts of exponentially growing cells, Gis1-myc 13 bound Cdc55-HA 3 or HA 3 -Pph21, but not HA 3 -Nap1 (control), whereas mutation of Ser 425 to Ala in Gis1 or treatment of cells with rapamycin strongly reduced the observed interactions ( Figure 3B ). Albeit Ser 425 is unlikely to be the only PP2A
-regulated phosphoresidue in Gis1, we addressed the possibility that phosphorylation of Gis1-Ser 425 may be functionally relevant in vivo. To this end, we used a PDS-lacZ reporter, which depends entirely on the presence of Gis1 for its expression following glucose-limitation (Pedruzzi et al., 2000) ( Figure 3C ). In these assays, Gis1 S425A -overexpressing cells exhibited significantly reduced PDS-lacZ expression when compared to Gis1-overexpressing control cells ( Figure 3C ). Similarly, plasmid-encoded, overexpressed Gis1 S425A was less efficient than Gis1 in restoring to msn2/4D gis1D triple mutants their ability to express RTN2 following rapamycin treatment ( Figure 3D) Figure 3D ), we observed that binding of Gis1 to the RTN2 promoter increased following rapamycin treatment and that this increase was significantly reduced when Ser 425 within Gis1 was mutated to Ala ( Figure 3E ). Moreover, loss of Rim15 or of Igo1/2 also diminished the rapamycin-induced recruitment of Gis1 to the RTN2 promoter, which could be largely prevented by introduction of a cdc55D mutation in these strains. Since loss of Rim15 or Igo1/2 affects RTN2 promoter binding of Gis1 more strongly than the Ser 425 to Ala mutation in Gis1 ( Figure 3E ), these data also indicate that PP2A Cdc55 regulates Gis1 promoter recruitment in part independently of Ser 425 . The phosphorylated serine or threonine residues are marked with an asterisk (S*/T*). For a detailed description of the selection criteria for peptides represented in this list, please see the text. Proteins are sorted by alphabetic order.
In conclusion, all of our data are consistent with a model in which Rim15 controls transcription of a specific set of nutrient-controlled genes by regulating the phosphorylation status, and hence promoter recruitment of Gis1 indirectly via the Igo1-PP2A Cdc55 effector branch. Extending our previous conclusions (Talarek et al., 2010) , our current study therefore suggests that Rim15 coordinates both aspects of gene expression, i.e., transcriptional activation and protection of the respective transcripts from 5 0 -3 0 mRNA decay pathway-mediated degradation, by activating Igo1/2 and consequent inhibition of PP2A
. Future studies should therefore address the possibility that Rim15 itself may be recruited to specific promoter regions to coordinate local activation of transcription and ensure cotranscriptional loading of activated Igo1 onto newly forming messenger ribonucleoprotein (mRNP) complexes, which may be key to control the phosphorylation status and activity of 5 0 -3 0 mRNA decay pathway proteins within these complexes. Notably, in this context, Vts1 (Table 1) binds an RNA motif, which occurs specifically in a set of genes that are induced in cells entering quiescence (Riordan et al., 2011) . In addition, a large fraction of the genes whose expression is most strongly affected by loss of Vts1 (including RTN2 and SOL4) appears to also be regulated by Rim15-Igo1/2 (Oberstrass et al., 2006; Talarek et al., 2010) . It will therefore be interesting to also explore a mechanistically different model in which temporally coordinated, but parallel regulation by the Igo1/2-PP2A Cdc55 module of both Gis1 and Vts1 may allow cells to coordinate transcription and posttranscriptional mRNA stability of Gis1-dependent genes containing a Vts1 RNAbinding motif. protein), and HA 3 -Pph21 (lanes 6, 7, 10, and 11) were immunoprecipitated (as in Figure 2B ) from extracts of exponentially growing (EXP) or rapamycin-treated (RAP; 90 min) cells coexpressing, or not (lane 2), Gis1-myc 13 (lanes 1, 3, 4, 6, 8, and 10) or Gis1 S425A -myc 13 (lanes 5, 7, 9, and 11). (C) PDS-LacZ expression (in Miller units) in glucose-limited (i.e.. postdiauxic) wild-type (GIS1; +) or gis1D (GIS1; D) cells carrying an empty vector (À), or a plasmid driving overexpression of wild-type Gis1-HA 3 (pGIS1-HA 3 ; +) or Gis1 S425A -HA 3 (pGIS1 S425A -HA 3 ; S425A).
(D) qRT-PCR analysis of RTN2 expression following rapamycin treatment (2.5 hr) in wild-type and indicated mutant cells carrying an empty vector (À), or a plasmid driving overexpression (from the ADH1 promoter) of wild-type Gis1-HA 3 (pGIS1-HA 3 ; +) or Gis1
S425A
-HA 3 (pGIS1
-HA 3 ; S425A). The value for the reference sample (rapamycin-treated wild-type cells) was normalized to 1.0. For details, see legend of Figure 1D . Protein levels of Gis1-HA 3 and Gis1
-HA 3 were verified by immunoblotting ( Figure S3) . (E) ChIP analysis of Gis1-HA 3 and Gis1 S425A -HA 3 recruitment to the RTN2 promoter (pRTN2; normalized with respect to the unrelated genomic region of STE3).
Gis1-HA 3 (pGIS1-HA 3 ; +) and Gis1 S425A -HA 3 (pGIS1 S425A -HA 3 ; S425A) were overexpressed from plasmids. ChIPs were performed in samples drawn either from exponentially growing (RAP; À) or rapamycin-treated (RAP; +; 2.5 hr) wild-type or indicated mutant strains. The value for the reference sample (exponentially growing wild-type cells overexpressing Gis1-HA 3 ) was normalized to 1.0. In Figures 2C-2E , each bar represents the mean ± SD of three experiments.
Together with previous studies (for a recent review, see Longo et al., 2012) , our current data show that the Rim15-Igo1/2-PP2A Cdc55 module represents an element of a TORC1-controlled effector branch, which plays a major role in shaping both the cellular quiescence program and CLS in yeast. Given the universal role of TORC1 in CLS regulation (Fontana et al., 2010) , as well as the remarkable conservation of the Rim15-Igo1/2-PP2A Cdc55 module, it will be interesting to examine whether the Gwl-Ensa/Arpp19-PP2A-B55d signaling branch may also regulate CLS in higher eukaryotes via similar mechanisms as described here in yeast. Conversely, given the important role of Gwl-Ensa/Arpp19-PP2A-B55d in regulating mitosis in higher eukaryotes (Mochida and Hunt, 2012) , future studies should also address the possibility that Rim15-Igo1/2-PP2A Cdc55 may contribute to the control of cell cycle events in yeast.
EXPERIMENTAL PROCEDURES
Strains, Growth Conditions, and Plasmids S. cerevisiae strains (Table S2) were grown at 30 C in standard rich medium (YPD) with 2% glucose or in synthetic defined (SD) medium (0.17% yeast nitrogen base, 0.5% ammonium sulfate, and 2% glucose) complemented with the appropriate nutrients for plasmid maintenance. Rapamycin was used at a concentration of 200 ng ml À1 . The plasmids used in this study are listed in Table S3 .
Quantitative Real-Time PCR Total RNA was extracted using the hot acidic phenol method. DNA was removed with the DNA-free Kit (Applied Biosystems) and first-strand cDNA was synthesized with the PrimeScript RT Reagent Kit (TaKaRa). Quantitative RT-PCR (qRT-PCR) was performed on a Rotor-Gene 6000 machine (Corbett Life Science), with the 5 3 EvaGreen QPCR Mix II (no Rox; Bio&SELL). Oligonucleotides used for qRT-PCR are listed in Table S4 . RTN2 and SOL4 mRNA levels were normalized with respect to TBP1 mRNA.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed mainly as published (Aparicio et al., 2005) using cells that were fixed for 15 min at 30 C with 1%
formaldehyde. The lysates were sonicated for six cycles (15 s on, 1 s off) with a Misonix 3000 sonicator. Gis1-HA 3 or Gis1
S425A
-HA 3 were IPed overnight at 4 C using anti-HA antibodies (ab9110; abcam) and protein-G agarose and DNA was analyzed by qPCR (see Table S4 for oligonucleotides). Signals for the RTN2 promoter were normalized with respect to the unrelated genomic region of STE3. triphosphate (Reinders et al., 1998 was not, subjected to in vitro phosphorylation by Rim15 prior to use. To assess PP2A activity, the released phosphate was measured using BIOMOL GREEN (ENZO Life Sciences).
Phosphatase Assays
CoIP and Phos-tag Phosphate-Affinity Gel Electrophoresis Cells were fixed ( Figures 2B and S2 ), or not ( Figure 3B ), for 20 min with 1% formaldehyde. After quenching with 0.3 M glycine, whole cell extracts were prepared and incubated with an anti-HA affinity matrix (clone 3F10; Roche). Phosphorylation of Gis1-HA 3 and Igo1-myc 8 was assessed by loading trichloroacetic acid (TCA) whole-cell extracts or lysates on 7.5% SDS-PAGE gels containing 25 mM Phos-tag (Wako).
Phosphoproteomics Sample Preparation and Analysis by Label-free Quantification All the budding yeast samples for the phosphoproteomics analysis were processed as described (Bodenmiller and Aebersold, 2010) . Briefly, cultures (all in triplicates) were incubated on ice for 10 min in the presence of 6.25% ice cold TCA before pelleting. For each replicate, 3 mg proteins were digested by trypsin (1:125 w/w) and cleaned by reverse-phase chromatography. Phosphopeptide isolation was performed by titanium dioxide resin (1.25 mg resin for each sample). Isolated phosphopeptides were analyzed by a LTQ FT Ultra mass spectrometer (Thermo Scientific, Germany), interfaced with a nanoelectrospray ion source. Chromatographic separation of peptides was performed on a Proxeon Easy-nLC II system (Odense, Denmark) using a 10.5 cm 3 75 mm column packed with 3 mm Magic C18 material. Peptides were separated at a flow rate of 300 nl min -1 with a gradient increasing from 5 to 40% acetonitrile.
The five most intense ions detected in each MS1 scan were selected for fragmentation. The mass spectrometry data were searched against an SGD decoy database for yeast proteins using Sequest (Lundgren et al., 2009) . OpenMS version 1.7 (Sturm et al., 2008) was used both to detect MS1 features and to align them between the different experimental conditions. By using a decoy database (Kä ll et al., 2008) , a Peptide Prophet's probability threshold was computed in order to achieve a false discovery rate below 1%, and was used to filter OpenMS results. Phosphopeptides features with identical sequence and phosphorylation state, but different charge states, were merged together.
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